000304477 001__ 304477
000304477 005__ 20250911114927.0
000304477 0247_ $$2doi$$a10.1186/s41181-025-00384-1
000304477 0247_ $$2pmid$$apmid:40921858
000304477 0247_ $$2pmc$$apmc:PMC12417351
000304477 037__ $$aDKFZ-2025-01869
000304477 041__ $$aEnglish
000304477 082__ $$a610
000304477 1001_ $$aKaur, Sarandeep$$b0
000304477 245__ $$aThe hydrogenation side-reaction in copper-mediated radiofluorination.
000304477 260__ $$a[Cham, Switzerland]$$bSpringer International Publishing$$c2025
000304477 3367_ $$2DRIVER$$aarticle
000304477 3367_ $$2DataCite$$aOutput Types/Journal article
000304477 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1757502472_23584
000304477 3367_ $$2BibTeX$$aARTICLE
000304477 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000304477 3367_ $$00$$2EndNote$$aJournal Article
000304477 520__ $$aCopper-mediated radiofluorination (CMRF) is a breakthrough in 18F-radiochemistry, enabling 18F incorporation into molecules even at electron-rich aromatic positions. In recent years, several improved protocols have been reported to advance the application of CMRF. These advancements primarily focus on improving radiochemical conversion, expanding substrate scope, and enabling scalability for remote-controlled radiotracer production. Despite these improvements, one major challenge remains: the protodemetallation. Protodemetallation is a common side reaction in transition metal-mediated cross-couplings that takes place by a mechanism that is not yet fully elucidated. In 18F-chemistry, the formation of the hydrogenated side product (HSP) can interfere with the chromatographic purification of the desired radiotracer, resulting in complex radiotracer production.The present work investigates the factors influencing the rate of the hydrogenation reaction as well as the source of hydrogen in the CMRF by use of model precursors bearing -B(OH)2, -Bpin, -BEpin and -SnBu3 as leaving groups. While the CMRF reactions are usually carried out under anhydrous conditions, the formation rate of the HSP was evaluated by controlling the chemical constituents (type and molarity of reagents) as well as the physical parameters (time and temperature). Moreover, experiments with deuterated reagents complemented by high-resolution mass spectrometry (HRMS) analysis were carried out to identify the source of hydrogen for the reductive elimination step.This study identifies reaction parameters that influence hydrogenation side reactions in CMRF, enabling high RCC with minimal HSP formation. The optimal reaction conditions include low temperature, short reaction time, and minimal amount of precursor, copper, and ideally no base and alcohols as solvents. Among the evaluated precursors, -BEpin afforded the lowest HSP formation, while -B(OH)2 afforded the highest. Overall, this study showed that the selection of proper reaction reagents and the fine-tuning of reaction parameters can substantially reduce the HSP formation while maintaining optimal radiochemical conversion.
000304477 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000304477 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000304477 650_7 $$2Other$$aBEpin
000304477 650_7 $$2Other$$aCMRF
000304477 650_7 $$2Other$$aCopper-mediated radiofluorination
000304477 650_7 $$2Other$$aFluorine-18
000304477 650_7 $$2Other$$aHydrogenated side product
000304477 650_7 $$2Other$$aProtodeboronation
000304477 7001_ $$aWenzel, Barbara$$b1
000304477 7001_ $$aOehme, Ramona$$b2
000304477 7001_ $$aWiesner, Claudia$$b3
000304477 7001_ $$0P:(DE-He78)9793347ba83f527b81a22ab75af9378a$$aKopka, Klaus$$b4
000304477 7001_ $$00000-0003-3119-7945$$aMoldovan, Rareş-Petru$$b5
000304477 773__ $$0PERI:(DE-600)2843088-8$$a10.1186/s41181-025-00384-1$$gVol. 10, no. 1, p. 60$$n1$$p60$$tEJNMMI radiopharmacy and chemistry$$v10$$x2365-421X$$y2025
000304477 909CO $$ooai:inrepo02.dkfz.de:304477$$pVDB
000304477 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9793347ba83f527b81a22ab75af9378a$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000304477 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000304477 9141_ $$y2025
000304477 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEJNMMI RADIOPHARM CH : 2022$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:38:06Z
000304477 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:38:06Z
000304477 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:38:06Z
000304477 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2024-04-10T15:38:06Z
000304477 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-27
000304477 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-27
000304477 9201_ $$0I:(DE-He78)DD01-20160331$$kDD01$$lDKTK Koordinierungsstelle Dresden$$x0
000304477 980__ $$ajournal
000304477 980__ $$aVDB
000304477 980__ $$aI:(DE-He78)DD01-20160331
000304477 980__ $$aUNRESTRICTED